# InteraXon

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/interaxon

- Industry: Medical Devices & Equipment
- Headquarters: Toronto, Canada
- Website: www.choosemuse.com
- Total disclosed funding: $38M
- Latest round: Series C (Aug 8, 2022)
- Investors on record: 18

## About

InteraXon Inc. develops innovative EEG-powered devices, notably the Muse headband, designed to enhance meditation and sleep quality through real-time neurofeedback and brain activity monitoring.Founded in 2009 in Toronto, Canada, InteraXon Inc. specializes in brain health technology. The company was co-founded by Ariel Garten, Chris Aimone, Steve Mann, and Trevor Coleman, and is currently led by CEO Jean-Michel Fournier. It has successfully completed 8 deals, with its most recent funding round, Series C, occurring in August 2022, raising USD 9.50 mn from investors including Alabaster and BDC Capital.InteraXon Inc. offers the Muse™ headband, which utilizes EEG and fNIRS technologies to monitor brain activity and blood flow. This device provides neurofeedback to help users improve their meditation and sleep experiences, targeting a wide audience from high-performance professionals to individuals focused on mental fitness.The company generates revenue through direct-to-consumer sales of Muse headbands and subscriptions for its mobile app, which offers guided meditations and sleep support. This diversified revenue model includes retail sales, app subscriptions, and partnerships with neuroscientists and sports organizations.In August 2022, InteraXon Inc. raised USD 9.50 mn in a Series C funding round to expand its brain health platform. The company plans to launch an integrated wellness membership and enhance offerings for developers, researchers, and clinicians, aiming for growth in diverse markets.

## Funding rounds

- Series C, Aug 8, 2022, $9.5M — BDC Capital, Export Development Canada, Phyto Partners, Xiamen Intretech Inc., Alabaster, Iter Investments, The Clavis Foundation
- Series B, Nov 7, 2017, $11M — Export Development Canada, OMERS Ventures, Build Ventures, Epic Capital Management, Bridge Builders Collaborative, Trend Forward Capital
- Series B, May 7, 2015, $10M — Felicis Ventures, OMERS Ventures, Horizons Ventures, Lab IX
- Series A, Aug 15, 2013, $6.7M — Felicis Ventures, ff Venture Capital, OMERS Ventures, Horizons Ventures, Sound Ventures, Bridge Builders Collaborative, 1440 Accelerator
- Seed, Mar 1, 2012, $0.5M — ff Venture Capital

## Investors

- ff Venture Capital (https://capitalatlas.ai/funds/ff-venture-capital) — Seed, Series A
- Felicis Ventures (https://capitalatlas.ai/funds/felicis-ventures) — Series A, Series B
- OMERS Ventures (https://capitalatlas.ai/funds/omers-ventures) — Series A, Series B
- Horizons Ventures — Series A, Series B
- Sound Ventures (https://capitalatlas.ai/funds/sound-ventures) — Series A
- Bridge Builders Collaborative (https://capitalatlas.ai/funds/bridge-builders-collaborative) — Series A, Series B
- 1440 Accelerator — Series A
- Lab IX — Series B
- Export Development Canada — Series B, Series C
- Build Ventures (https://capitalatlas.ai/funds/build-ventures) — Series B
- Epic Capital Management — Series B
- Trend Forward Capital (https://capitalatlas.ai/funds/trend-forward-capital) — Series B
- BDC Capital (https://capitalatlas.ai/funds/bdc-capital) — Series C
- Phyto Partners (https://capitalatlas.ai/funds/phyto-partners) — Series C
- Xiamen Intretech Inc. — Series C
- Alabaster (https://capitalatlas.ai/funds/alabaster) — Series C
- Iter Investments (https://capitalatlas.ai/funds/iter-investments) — Series C
- The Clavis Foundation — Series C